IMMX icon

Immix Biopharma
IMMX

Overview Fund Activity

25 hedge funds and large institutions have $6.1M invested in Immix Biopharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.

Holders
25
Holders Change
-6
Holders Change %
-19.35%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
7
Reduced
4
Closed
6
Calls
$13K
Puts
$2K
Net Calls
+$11K
Net Calls Change
+$11K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.04M
2
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$125K
3
Morgan Stanley
3
Morgan Stanley
New York
$126K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$224K
5
TAM
5
Tocqueville Asset Management
New York
$64.5K

Top Sellers

1
ACM
1
AIGH Capital Management
Maryland
$1.67M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$0
3
FIA
3
FNY Investment Advisers
New York
$0
4
PAG
4
Private Advisor Group
New Jersey
$51.1K
5
Squarepoint
5
Squarepoint
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Renaissance Technologies
26
Renaissance Technologies
New York
– – -154,685 Closed
FIA
27
FNY Investment Advisers
New York
– – -32,500 Closed
Squarepoint
28
Squarepoint
New York
– – -23,010 Closed
XT
29
XTX Topco
Cayman Islands
– – -17,663 Closed
CCM
30
Corsair Capital Management
New York
– – -14,217 Closed
Simplex Trading
31
Simplex Trading
Illinois
– – -449 Closed
Citadel Advisors
32
Citadel Advisors
Florida
– – – –
CFGS
33
Concourse Financial Group Securities
Alabama
– – – –
1
2